Olivier Benveniste

Long‐term outcome of patients with polymyositis/ dermatomyositis and anti‐PM‐Scl antibody

L. Mouthon, E. Hachulla, I. Marie, 2010, The British journal of dermatology.

French expert opinion for the management of juvenile dermatomyositis.

E. Hachulla, B. Bader-Meunier, A. Belot, 2019, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Where Are We?

O. Landon-Cardinal, Olivier Benveniste, Yves Allenbach, 2024, Current Treatment Options in Rheumatology.

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

P. Grenier, M. Guiguet, E. Hachulla, 2015, PloS one.

Pathologic Features of Anti-Ku Myositis.

A. Uruha, M. Oyama, Y. Nishimori, 2024, Neurology.

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

S. Ederhy, J. Cautela, M. Rosenzwajg, 2023, Nature medicine.